Fri, January 24, 2025

by: WOPRAI

Wamsi Mohan Maintained (AAPL) at Buy with Decreased Target to $253 on, Jan 24th, 2025

by: WOPRAI

Paul Lejuez Reinstated (ACI) to Buy and Held Target at $26 on, Jan 24th, 2025

by: WOPRAI

Brett Fishbin Maintained (ALC) at Overweight with Decreased Target to $105 on, Jan 24th, 2025

by: WOPRAI

David Saxon Maintained (ALC) at Buy with Decreased Target to $106 on, Jan 24th, 2025

by: WOPRAI

Gregory Renza Reiterated (AMGN) at Outperform and Held Target at $324 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (AMH) at Equal with Decreased Target to $37 on, Jan 24th, 2025

by: WOPRAI

David George Maintained (ASB) at Neutral with Decreased Target to $26 on, Jan 24th, 2025

by: WOPRAI

Karl Shepard Maintained (ASB) at Sector with Increased Target to $27 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Downgraded (AVB) to Equal and Decreased Target to $223 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (AVB) at Equal with Decreased Target to $230 on, Jan 24th, 2025

by: WOPRAI

Jason Gursky Maintained (BA) at Buy with Decreased Target to $207 on, Jan 24th, 2025

by: WOPRAI

Jared Shaw Maintained (BANC) at Overweight with Decreased Target to $19 on, Jan 24th, 2025

by: WOPRAI

David Williams Reiterated (BDC) at Buy and Held Target at $130 on, Jan 24th, 2025

by: WOPRAI

Fawne Jiang Reiterated (BIDU) at Buy and Held Target at $130 on, Jan 24th, 2025

by: WOPRAI

Joseph Greff Maintained (BYD) at Neutral with Increased Target to $80 on, Jan 24th, 2025

Thu, January 23, 2025

by: MSN

Avidity Biosciences CFO sells $93,985 in stock

Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company stock valued at approximately $93,985. The transactions occurred on January 21,

by: MSN

2 'Strong Buy'-Rated Dividend Stocks With Yields Above 7% for 2025

Investing in dividend stocks with a high yield of more than 7% can significantly boost your portfolio's income potential, especially in a low-interest-rate environment. However, targeting companies with sustainable dividend payouts is crucial,

by: MSN

Altimmune's SWOT analysis: pemvidutide potential drives stock outlook

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on developing treatments for liver disease and obesity, has been garnering attention from analysts and investors alike.

by: MSN

Diamondback Energy's SWOT analysis: stock poised for growth amid merger synergies

Diamondback Energy Inc (NASDAQ:FANG), a leading independent oil and gas company focused on the Permian Basin with a market capitalization of $51.48 billion, has been making significant strides in operational efficiency and strategic growth.

by: Forbes

S&P 500 Index Funds: Risks You Must Know Before You Invest

Low cost S&P 500 index funds are fantastic investment vehicles but they are not without risks. We discuss these risks and how to best think about them.

by: MSN

Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking

The exposé led to the company's CEO going to jail and to Anderson's short-selling firm, Hindenburg Research, becoming one of the most feared names in corporate America. When Anderson announced last Wednesday that Hindenburg was closing shop,

by: MSN

Is AbbVie Inc. (ABBV) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other halal dividend stocks.

by: MSN

Is Intel Corporation (INTC) One of the Best Socially Responsible Stocks to Buy According to Hedge Funds?

We recently compiled a list of the 8 Best Socially Responsible Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Intel Corporation (NASDAQ:INTC) stands against other best socially responsible stocks to buy according to hedge funds.

by: Forbes

Is Quantum Computing Investable As The Next AI

Quantum computing has the potential of being the next big innovation. At the right size and the right price, it might even be investable.

by: MSN

Is Johnson & Johnson (JNJ) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other halal dividend stocks.

by: MSN

BlackRock CEO Fink advocates for tokenization of stocks and bonds

In a recent public statement, Larry Fink, the Chief Executive Officer of BlackRock (NYSE:BLK), expressed his support for the Securities and Exchange Commission (SEC) to approve the tokenization of bonds and stocks.

by: MSN

Is PepsiCo, Inc. (PEP) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where PepsiCo, Inc. (NASDAQ:PEP) stands against the other halal dividend stocks.

by: AOL

Warren Buffett: 5 Stocks He's Dead Serious About In 2025

Warren Buffett, the legendary investor known as the "Oracle of Omaha," continues to make waves in the financial world even as he approaches his mid-90s. His company, Berkshire Hathaway, has been

by: MSN

Is Medtronic plc (MDT) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other halal dividend stocks.

by: Forbes

What Are The Risks Of S&P 500 Index Funds?

Low cost S&P 500 index funds are fantastic investment vehicles but they are not without risks. We discuss these risks and how to best think about them.

by: MSN

How to Get Your Kids into Investing: A Family Project to Try

To teach your children about investing, put your money where your mouth is with this fun and potentially profitable exercise.

by: WOPRAI

Short squeeze is starting in shares of TENB at $42.81, after crossing above the $42.514 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of UGI at $30.349, after crossing above the $30.301 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SD at $12.4, after crossing above the $12.372 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PHG at $26.52, after crossing above the $26.497 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of LVO at $1.25, after crossing above the $1.222 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of IVDN at $0.32, after crossing above the $0.277 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of FMS at $24.31, after crossing above the $23.655 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BWB at $13.545, after crossing above the $13.387 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BUSE at $23.04, after crossing above the $22.952 Trigger Price

by: MSN

Dave Ramsey: If You Invested $10K in These Companies, You'd Be Nearly $16K Richer

Unlike many finance experts and investors, Dave Ramsey does not recommend investing in S&P 500 stocks. You won't see names like Apple or Amazon in his portfolio -- at least not directly.

by: MSN

The Worst Mistakes Almost Every TFSA Holder Makes, and the CRA Is Watching

The TFSA is great, sure, but these mistakes could be keeping you from creating cash. The post The Worst Mistakes Almost Every TFSA Holder Makes, and the CRA Is Watching appeared first on The Motley Fool Canada.

by: WOPRAI

Short squeeze is starting in shares of TXO at $19.41, after crossing above the $19.19 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of INSW at $36.97, after crossing above the $36.852 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CASS at $42.45, after crossing above the $41.318 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of AMTB at $24.195, after crossing above the $23.134 Trigger Price

by: AOL

Will This 1 New Development Be a Game-Changer for Solana Investors?

When it comes to cryptocurrencies that are currently in the limelight, few are more compelling to invest in than Solana (CRYPTO: SOL). Let's investigate what they're excited about, the potential impacts on the coin's price,

by: WOPRAI

Short squeeze is starting in shares of SLAMU at $10.62, after crossing above the $10.123 Trigger Price

Is Intel Corporation (INTC) One of the Best Socially Responsible Stocks to Buy According to Hedge Funds?

We recently compiled a list of the 8 Best Socially Responsible Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Intel Corporation (NASDAQ:INTC) stands against other best socially responsible stocks to buy according to hedge funds.

The article discusses whether Intel Corporation (INTC) is considered one of the best socially responsible stocks to buy, based on hedge fund investments and its corporate social responsibility (CSR) efforts. Intel has been recognized for its commitment to sustainability, diversity, and inclusion, with initiatives like aiming for 100% renewable energy use by 2030 and achieving gender pay equity. Hedge funds like Citadel Investment Group and AQR Capital Management have shown significant interest in Intel, with the company ranking 17th on a list of socially responsible stocks favored by hedge funds. Intel's efforts in reducing greenhouse gas emissions, water usage, and waste, along with its focus on ethical supply chain practices, underline its appeal as a socially responsible investment. However, the article also notes that while Intel scores well on CSR, its stock performance and other financial metrics should also be considered by potential investors.

Read the Full MSN Article at:
https://www.msn.com/en-us/technology/general/is-intel-corporation-intc-one-of-the-best-socially-responsible-stocks-to-buy-according-to-hedge-funds/ar-AA1xKwOr